Novo Nordisk Donates License For Small-Molecule Compound Library To China, WHO
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Denmark-based Novo Nordisk will donate a license to its small molecule compound library to China's National Center for Drug Screening, the company announced April 28 in Copenhagen.You may also be interested in...
Novo Nordisk To Construct One Of World’s Largest Insulin Plants In Tianjin, China, Biopharma Center
Novo Nordisk To Construct One Of World’s Largest Insulin Plants In Tianjin, China Biopharma Center
Novo Nordisk To Construct One Of World’s Largest Insulin Plants In Tianjin, China, Biopharma Center
Need a specific report? 1000+ reports available
Buy Reports